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indoleamine 2,3-dioxygenase (IDO) were analysed and related to the
Best Keeper Index with GAPDH, HPRT and UBC as house keeping genes.
Statistical analysis was performed using a mixed model ANOVA, in which
treatment was considered a ﬁxed factor and the different synovial ﬂuid
donors a random factor. A P-value of <0.05 was considered statistically
signiﬁcant.
Results: Synovial ﬂuid in general upregulated the expression of IL-6
(2.7±1.6 fold, p = 0.045), IDO (4.1±2.7 fold, p = 0.013) and TNFa (2.9±2.0
fold, p = 0.046) in MSCs, while HGF and TGFb1 gene expressions were
not affected (Figure 1).
Synovial ﬂuid of OA patients induced a 1.69±1.47 fold (p = 0.031) higher
expression of IDO than synovial ﬂuid of healthy donors. No further
differences between synovial ﬂuid of OA and RA patients compared to
healthy donors on the gene expression of MSCs were found.
Conclusions: Synovial ﬂuid inﬂuences the expression of genes involved
in immunomodulation in MSCs. The upregulated expression of IL-6, TNFa
and IDO could indicate a response of the MSCs to inﬂuence the balance
between the catabolic and anabolic state. IDO is an immunomodulatory
enzyme that catalyzes the ﬁrst and rate-limiting step in the kynurenine
pathway thereby inhibiting T-cell proliferation and stimulating the
differentiation of regulatory T-cells. The upregulated expression of IDO
by OA versus healthy synovial ﬂuid indicates that MSCs can be triggered
to exert anti-inﬂammatory effects in a diseased joint.
These results suggest a possible anti-inﬂammatory effect MSCs could
have intra-articular in a diseased joint and stimulate further study of
MSCs as treatment for OA and RA.
Fig. 1. Effect of synovial ﬂuid on gene expression of immunomodulatory
factors by MSCs.
475
CHONDROGENIC DIFFERENTIATION OF BONE MARROW
MESENCHYMAL STEM CELLS (BM-MSCS) GROWN ON COLLAGEN
POROUS SCAFFOLDS
S. Diaz-Prado1,2, E. Muin˜os-Lopez1, T. Hermida-Go´mez1, I.M. Fuentes1,2,
P. Esbrit3, J. Buja´n4, F.J. De Toro1,2, F.J. Blanco1. 1INIBIC-CHUAC, A Corun˜a,
Spain; 2INIBIC-Univ. of A Corun˜a, A Corun˜a, Spain; 3Fundacio´n Jime´nez
Dı´az (Capio Group), Madrid, Spain; 4Dept. of Med. Specialties, Univ. of
Alcala´ de Henares, Madrid, Spain
Purpose: To study the chondrogenic potential of human bone marrow
mesenchymal stem cells (hBM-MSCs) grown on a mixture of type I and
II collagen supports.
Methods: hBM-MSCs were isolated from human BM stroma and were
expanded in monolayer cultures. hBM-MSCs were characterized by ﬂow
cytometry using hematopoietic and MSC markers. At the 3–4th passage,
hBM-MSCs were cultured on 1x1 cm2type I/II collagen porous supports,
pre-treated or not with PTHrP (1–36) or PTHrP (107–139) (100 nM) for 1.5
h. The cell density over the support was 50.000 cells/cm2. We performed
18 groups: 9 in normoxia (humidiﬁed atmosphere with 5% CO2) and
the other 9 in hypoxia conditions (obtained with GasPak™ EZ Anaerobe
Pouch System, BD Diagnostics). Within each group, 5 replicas were done.
The study period was 14 days for the groups tested in hypoxia and
21 days for those in normoxia. hBM-MSCs were cultured in chondrogenic
differentiation medium (Lonza, Group Ltd, Switzerland) or DMEM with
20% FBS. Control groups were mature human chondrocytes grown in
DMEM with 10% FBS. Chondrogenic differentiation was conﬁrmed by
histochemical and immunohistochemical analysis
Results: By means of hematoxylin-eosin stainings it was found that both
hBM-MSCs and chondrocytes were able to grow on collagen type I/II
supports, not only in the presence (C-terminal and N-terninal PTHrP)
but also in the absence of PTHrP. However cultures without PTHrP
showed a lower rate of cell proliferation. Moreover, in some study
groups it was observed the production of an extracellular matrix. At
the same time that hBM-MSCs proliferated over the support, they were
able to degrade the biomaterial although it is important to note that
larger collagen ﬁbers are more difﬁcult to be degraded by the cells.
It was observed that cells were interconnected with each other and
also with the biomaterial, so that they were radiating from the center
toward the edge of the support. The hBM-MSCs grown in chondrogenic
medium were able to differentiate into cells that showed characteristics
similar to chondrocytes. To demonstrate the chondrogenic differentiation
some immunostainings were performed in order to detect the presence
of different characteristic components of the articular cartilage. As it
is shown in Figure 1, the cells showed positive immunostaining for
collagen II and one of the most abundant proteoglycan of cartilage
(aggrecan). Moreover, positivity for types I and X collagens and MMP13
was also observed. In the case of immunohistochemistry for PCNA, a
marker of proliferation, it was observed that cells despite being in
culture over the biomaterial for 14 and 21 days, they proliferated without
showing any sign of apoptosis or senescence.
Conclusions: Our data demonstrate that type I/II collagen scaffolds are
optimal for hBM-MSCs and chondrocyte growth. Moreover, both N- and
C-terminal fragments of PTHrP improve the capacity of hBM-MSCs to
differentiate into chondrocyte-like cells.
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Fig. 1. Immunohistochemistry (A) and semi-quantitative (B) analysis of
hBM-MSCs grown on type I/II collagen supports in normoxia conditions
and in chondrogenic medium. Col-I, -II, -X: collagen types I, II and X.
PCNA: proliferating cell nuclear antigen. MMP-13: metalloproteinase 13.
Image magniﬁcation 10×.
